Ramdan Hours:
Sun - Thu
9.30 AM - 2.30 PM
Iftar in --:--:--
🌙 Maghrib: --:--

Gene therapy / (Record no. 10422)

MARC details
000 -LEADER
fixed length control field 01525nam a2200289 i 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230911142604.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 160211s2007 muaa|||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0805338195
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780805338195
040 ## - CATALOGING SOURCE
Original cataloging agency EG-NcFUE
Description conventions rda
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Edition number 23
Classification number 616.042
Item number C.M.G
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Colavito, Mary C.
Relator term author
245 10 - TITLE STATEMENT
Title Gene therapy /
Statement of responsibility, etc Mary C. Colavito.
264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc San Francisco :
Name of publisher, distributor, etc Pearson,
Date of publication, distribution, etc [2007],
300 ## - PHYSICAL DESCRIPTION
Extent iv, 42 pages :
Other physical details illustrations ;
Dimensions 24 cm.
336 ## - CONTENT TYPE
Content type term text
Source rdacontent
337 ## - MEDIA TYPE
Media type term unmediated
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term volume
Source rdacarrier
490 0# - SERIES STATEMENT
Series statement Benjamin/Cummings special topics in biology series
500 ## - GENERAL NOTE
General note pharmacy bookfair2016
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Realizing the promise of gene therapy : successes, setbacks, and challenges -- Gene therapy methods. Identifying a disease that is likely to respond to gene therapy ; Isolating a functional copy of the gene ; Incorporating the gene into a carrier for gene delivery ; Determining whether the gene product is made --<br/>Partial successes and ongoing trials. Gene therapy for severe combined immune deficiency (ADA-SCID) ; Gene therapy for cystic fibrosis ; Gene therapy for canavan disease --<br/>Setbacks. Immune reactions targeting cells carrying the vector ; Inadvertent activation of cancer causing genes by a vector ; Insufficient numbers of cells producing the gene product.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Gene therapy.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Genetic Therapy.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Books
Holdings
Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Home library Current library Shelving location Date acquired Source of acquisition Cost, normal purchase price Acquisition method Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
  Dewey Decimal Classification     Pharmacy ( Pharmacology ) Main library Main library A11 11/02/2016 Mediterranean Publishers Services 200.00 Purchase   616.042 C.M.G 00012747 19/02/2025 11/02/2016 Books